(benzyloxycarbonyl) derivative (S,S)-5, whose chiral HPLC
analysis showed an 87% ee. In this case, we obtained a very
high apparent enantioselectivity (E > 200)12 calculated from
both ee values.
Scheme 1a
The formation of (R,R)-3 involves two biocatalytic steps
[diamine to mono(amidoester) to bis(amidoester)] and,
therefore, the above-mentioned enantiopurity of (R,R)-3 has
to be clearly determined by the enantioselectivities of both
steps. To study the enantioselectivity shown by the CALB
in each step, we have calculated E1 and E2 values. The lability
of 1 toward oxidation, as well as the final persistence of
trace amounts of mono(amidoester) (detected in the deriva-
tization process of 4), made the accurate determination of
the reaction conversion c difficult. For these reasons, E1 was
determined when a 2:1 molar ratio of diamine:acyl donor
was used and the reaction stopped at the mono(amidoester)
stage (Scheme 1). In this process, substrate 1 and product 6
were isolated as their benzyl carbamates (S,S)-5 and (R,R)-
7, with 83 and 66% ees, respectively. The enantioselectivity
(E1 ) 21) and conversion (c ) 44%) were determined from
these values.12 This enantioselectivity value is not high
enough to get the product in enantiopure form, so the second
aminolysis step must also be enantioselective.
a Reaction conditions: (a) 1:1 molar ratio of (()-trans-1/2,
CALB, 1,4-dioxane, 30 °C; (b) 2 N HCl; (c) CbzCl, Na2CO3, H2O;
(d) 2:1 molar ratio of (()-trans-1:2, CALB, 1,4-dioxane, 30 °C, 1
h; (e) NH3, MeOH; (f) BH3‚THF, 6 N HCl, 4 N NaOH.
tion. This strategy has been successfully used for the
preparation of optically active trans-cyclohexane-1,2-di-
amine.7 With a suitable acyl donor, the appropriate enzyme
can catalyze the enantioselective monoacylation of the
diamine and subsequent enantioselective acylation of the
resulting optically enriched monoamide, thus affording an
enantiomerically pure diamide. The potential importance of
trans-cyclopentane-1,2-diamine (1) led us to explore the
resolution of this diamine8 by means of two sequential
aminolysis reactions, using dimethyl malonate (2) as the acyl
donor and Candida antarctica lipase (CALB) as the catalyst.
The selection of the acyl donor is associated to the synthetic
utility of the resulting products for the preparation of optically
active polyamines and macrocycles.9 It is remarkable that,
although (()-trans-cyclohexane-1,2-diamine is commercially
available, the (()-trans-cyclopentane-1,2-diamine is not.
Therefore, it has been scarcely studied, and it would be of
great interest to find an efficient procedure for obtaining
enantiopure trans-cyclopentane-1,2-diamine.
Enantioselectivity of the second step (E2) was also
determined from the single-step aminolysis reaction between
racemic mono(amidoester) 6 and dimethyl malonate 2
(Scheme 2).
Scheme 2a
Commercially available (()-trans-cyclopentane-1,2-diol
was transformed into (()-trans-cyclopentane-1,2-diamine (1)
using a procedure described in the literature.10
A one-pot double-acylation reaction (Scheme 1) using an
equimolecular mixture of (()-trans-1 and 2 with CALB11
in 1,4-dioxane (9 h) afforded enantiopure bis(amidoester)
(R,R)-3. The unreacted (S,S)-1 was isolated as its diammo-
nium salt, (S,S)-4, formed by treatment of the reaction
mixture with 2 N HCl. To determine the optical purity of
(S,S)-1, its salt (S,S)-4 was converted into the N,N′-bis-
a Reaction conditions: (a) 1:0.5 molar ratio of (()-trans-1/CbzCl,
Na2CO3, CH2Cl2; (b) ClC(O)CH2CO2Me, Et3N, CH2Cl2; (c) H2,
Pd-black, MeOH; (d) 2:1 molar ratio of (()-trans-6/1, CALB, 1,4-
dioxane, 30 °C, 3 h; (e) CbzCl, Na2CO3, H2O.
Compound 6 was prepared from (()-trans-1 by mono-
protection with benzyloxycarbonyl group, treatment with
malonyl chloride monomethyl ester, and finally removal of
the Cbz group (50% yield). Enzymatic aminolysis of (()-
trans-6 and 2 (molar ratio ) 2:1) yielded a mixture of (S,S)-
6, isolated as its carbamate (S,S)-7, and the bis(amidoester)
(R,R)-3 both in enantiomerically pure forms (ee > 99%).
Conversion (c ) 49%) and enantioselectivity (E2 > 200)
were also determined from these values.12
(7) Alfonso, I.; Astorga, C.; Rebolledo, F.; Gotor, V. Chem. Commun.
1996, 2471.
(8) Dominguez, B.; Hodnett, N. S.; Lloyd-Jones, G. C. Angew. Chem.,
Int. Ed. 2001, 40, 4289.
(9) (a) Alfonso, I.; Rebolledo, F.; Gotor, V. Tetrahedron: Asymmetry
1999, 10, 367. (b) Alfonso, I.; Rebolledo, F.; Gotor, V. Tetrahedron:
Asymmetry 1999, 10, 2515. (c) Alfonso, I.; Dietrich, B.; Rebolledo, F.;
Gotor, V.; Lehn, J. M. HelV. Chim. Acta 2001, 280. (d) Alfonso, I.;
Rebolledo, F.; Gotor, V. Chem. Eur. J. 2000, 6, 3331.
(10) (a) Or, Y. S.; Phan, L. T.; Chan, D. T.; Spina, K. P.; Halla, R.;
Elliot, R. L. WO Patent 9 717 356, 1997; Chem. Abstr. 1997, 127, 34467.
(b) Ongeri, S.; Aitken, D. J.; Husson, H.-P. Synth. Commun. 2000, 30, 2593.
(11) Catalyst can be reused several times.
In this biocatalytic process, CALB clearly shows the same
stereochemical preference toward the (R,R)-enantiomer of
the substrate in both steps. This fact and the strategy of the
(12) Chen, C.-S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J. Am. Chem.
Soc. 1982, 104, 7294.
3628
Org. Lett., Vol. 4, No. 21, 2002